Roche Holding AG Retained Earnings (Accumulated Deficit) 2010-2023 | RHHBY

Roche Holding AG retained earnings (accumulated deficit) from 2010 to 2023. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

Roche Holding AG Retained Earnings (Accumulated Deficit) 2010-2023 | RHHBY

Roche Holding AG retained earnings (accumulated deficit) from 2010 to 2023. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$711.9B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$374.4B
AbbVie (ABBV)$303.5B
Merck (MRK)$252.6B
Novartis AG (NVS)$212.3B
AstraZeneca (AZN)$199.2B
Pfizer (PFE)$142.4B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B